Statin Use May Reduce All-Cause, CVD Mortality in Older Patients
In US veterans aged 75 years and older, statin use is associated with reduced all-cause and cardiovascular mortality.
Dyslipidemia
New Algorithm Proposed for Dysbetalipoproteinemia Diagnosis
An algorithm using simple clinical variables was proposed for the diagnosis of dysbetalipoproteinemia.
Modest Reductions in LDL-C in ASCVD Associated With Low Adherence, Prescribing of High-Intensity Statin Therapy
Suboptimal adherence to and low prescribing of high-intensity statin therapy may be associated with the modest reductions in LDL-C observed in patients with ASCVD.
Association Found Between HDL-C Levels, Variability and Risk for Stroke, MI, Mortality
Low mean levels and high variability of HDL-C were found to be associated with increased risks for stroke, myocardial infarction and all-cause mortality.
Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Early Up-Titration to High-Intensity Statins May Reduce CV Events in Patients at Very High Risk for ASCVD
Up-titration to high-intensity statins early on in the course of treatment was found to be associated with a lower risk for cardiovascular (CV) events compared with no up-titration in patients at very high risk for CV disease.
What Causes Elevated Lipoprotein(a) Levels in Familial Hypercholesterolemia?
Elevated lipoprotein(a) levels was not found to be caused by FH, but may help with clinical recognition of genetic FH.
Traits Associated With T2D Risk in Adulthood Are Detectable by Age 8 Years
Metabolic traits associated with adult diabetes risk may be detectable by age 8 years.
Meta-Analysis: Metabolic Outcomes Improve After Revisional Bariatric Surgery
Revisional bariatric surgery in patients with persistent metabolic disease may improve obesity-related comorbidities and metabolic outcomes.
Risk for PAD Events May Be Related to Lipoprotein(a) Levels, Reduced by Alirocumab After ACS
The risk for peripheral artery disease events was found to be associated with levels of lipoprotein(a) in patients with recent acute coronary syndrome.
-
Loading...
-
Loading...
Next post in Cardiovascular and Metabolic Disorders
